日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

一项针对未经治疗的转移性胰腺腺癌患者的吉西他滨/白蛋白紫杉醇联合纳武利尤单抗/伊匹木单抗或羟氯喹/伊匹木单抗的1期临床试验的临床和转化结果

O'Reilly, Eileen M; Cabanski, Christopher R; Lyman, Jaclyn P; Wainberg, Zev A; Fisher, George A; Wolff, Robert A; Ko, Andrew H; O'Hara, Mark H; Spencer, Christine N; Yu, Jia Xin; Da Silva, Diane M; Padrón, Lacey J; Arnott, Jamie; Fairchild, Justin; Moore, Jonni S; Peng, Brandon; Hoos, William A; O'Donnell-Tormey, Jill; Boffo, Silvia; Dugan, Ute; Kimmelman, Alec C; Amaravadi, Ravi K; Vonderheide, Robert H

IL-10R inhibition induces neutrophil tumoricidal activity.

IL-10R抑制可诱导中性粒细胞的杀瘤活性。

Khalil Danny N, Gomez Ricardo, Regev Amit, Samaan Fadi, Marouf Yacine, Budhu Sadna, Hirschhorn Daniel, Schulze Isabell, Lavery Jessica A, Ceglia Nicholas, Freeman Samuel S, Maltez Vivien I, Garcia Jaynia M, Suek Nathan, Weng Chien-Huan, Cabanski Christopher R, Monette Sebastien, Romin Yevgeniy, Li Yanyun, Chaligne Ronan, Yellin Michael J, Keler Tibor, Maurer Deena M, Flamar Anne-Laure, Morgado-Palacin Lucia, Mangarin Levi M, Harding James J, Park Wungki, Lyman Jaclyn P, Maddock Stephen, O'Hara Mark H, Abou-Alfa Ghassan K, Vonderheide Robert H, O'Reilly Eileen M, Germain Ronald N, Wolchok Jedd D, Merghoub Taha

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials

自体细胞基因疗法中人为引入异质性:首次人体试验的战略考量

Cabanski, Christopher R; Yang, EnJun; Stewart, Mark D; Allen, Jeff D; Connolly, John E; Dugan, Ute; Greenberg, Philip D; Mackall, Crystal L; June, Carl H; Marson, Alexander; Maus, Marcela V; Ribas, Antoni

Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recovery

通过灵活的生产和成本回收方式,实现对基因修饰细胞疗法的可及性。

Stewart, Mark D; Cabanski, Christopher R; Allen, Jeff D; Connolly, John E; Beneski, Ben M; Dropulić, Boro; Feldman, Steven A; Fleisher, Lee A; Hanley, Patrick J; Hege, Kristen; Kekre, Natasha; Fernandez Lynch, Holly; Mackall, Crystal L

Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PORTER研究的临床和转化结果:一项针对转移性去势抵抗性前列腺癌的联合免疫疗法多队列I期平台试验

Galsky, Matthew D; Autio, Karen A; Cabanski, Christopher R; Wentzel, Kristopher; Graff, Julie N; Friedlander, Terence W; Howes, Timothy R; Shotts, Kristin M; Densmore, Julie; Spasic, Marko; Da Silva, Diane M; Chen, Richard O; Lata, Jennifer; Skolnik, Jeffrey; Keler, Tibor; Yellin, Michael J; LaVallee, Theresa M; Fairchild, Justin; Boffo, Silvia; O'Donnell-Tormey, Jill; Dugan, Ute; Bhardwaj, Nina; Subudhi, Sumit K; Fong, Lawrence

Germline microRNA-based signatures predict toxicity and response to anti-CTLA-4 therapy

基于种系microRNA的特征可以预测抗CTLA-4疗法的毒性和疗效

Weidhaas, Joanne B; McGreevy, Kristen M; Marco, Nicholas; Sundahl, Nora; Cabanski, Christopher R; Spencer, Christine; LaVallee, Theresa; Ost, Piet; Telesca, Donatello

Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity

黑色素瘤中随机安慰剂对照、生物标志物分层的 Ib 期微生物组调节:抗生素预处理对微生物组和免疫的影响

Isabella C Glitza #, Yongwoo David Seo #, Christine N Spencer #, Jennifer R Wortman #, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan Hicks, Joh

Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer

晚期转移性癌症患者对纳武利尤单抗联合伊匹木单抗治疗的反应和耐药的免疫学特征

Apostolia M Tsimberidou # ,Farah A Alayli # ,Kwame Okrah # ,Alexandra Drakaki ,Danny N Khalil ,Shivaani Kummar ,Saad A Khan ,F Stephen Hodi ,David Y Oh ,Christopher R Cabanski ,Shikha Gautam ,Stefanie L Meier ,Meelad Amouzgar ,Shannon M Pfeiffer ,Robin Kageyama ,EnJun Yang ,Marko Spasic ,Michael T Tetzlaff ,Wai Chin Foo ,Travis J Hollmann ,Yanyun Li ,Matthew Adamow ,Phillip Wong ,Jonni S Moore ,Sharlene Velichko ,Richard O Chen ,Dinesh Kumar ,Samantha Bucktrout ,Ramy Ibrahim ,Ute Dugan ,Lisa Salvador ,Vanessa M Hubbard-Lucey ,Jill O'Donnell-Tormey ,Sandra Santulli-Marotto ,Lisa H Butterfield ,Diane M Da Silva ,Justin Fairchild ,Theresa M LaVallee ,Lacey J Padrón ,Padmanee Sharma

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

吸入型抗TSLP抗体片段ecleralimab可阻断轻度哮喘患者对过敏原的反应

Gauvreau, Gail M; Hohlfeld, Jens M; FitzGerald, J Mark; Boulet, Louis-Philippe; Cockcroft, Donald W; Davis, Beth E; Korn, Stephanie; Kornmann, Oliver; Leigh, Richard; Mayers, Irvin; Watz, Henrik; Grant, Sarah S; Jain, Monish; Cabanski, Maciej; Pertel, Peter E; Jones, Ieuan; Lecot, Jean R; Cao, Hui; O'Byrne, Paul M

The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling

核糖体S6激酶2 (RSK2)-SPRED2复合物调节RSK底物的磷酸化和MAPK信号传导

Jocelyne Lopez ,Daniel A Bonsor ,Matthew J Sale ,Anatoly Urisman ,Jennifer L Mehalko ,Miranda Cabanski-Dunning ,Pau Castel ,Dhirendra K Simanshu ,Frank McCormick